Menu
Not yet recruiting NCT06190080

Outcome of Children With Eosinophilic Esophagitis

No phase Interventional Esophagitis, Eosinophilic

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Digestive endoscopy.
Who it may be relevant to
Registry conditions: Esophagitis, Eosinophilic. Basic parameters: 2 years — 17 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Outcomes of Children With Eosinophilic Esophagitis: a Prospective Monocentric Observational Study

Overview

The investigator would like to create a prospective cohort of patients in order to describe eosinophilic esophagitis with the specificities corresponding to our geographical territory, and to study their evolution at 3 months, 6 months, 12 months, 18 months and 24 months. This study would also enable us to investigate the quality of life of these chronically ill patients

Detailed description

The investigator would like to create a prospective cohort of 16 patients included over 2 years in order to determine the rate of complete remission (clinical, endoscopic and histological) at 3 months, 6 months, 12 months, 18 months and 24 months of treatment initiation. It is also planned to describe this cohort of pediatric EO patients at inclusion and throughout follow-up, and to study their quality of life.

Follow-up visits is organized every 3 months with a gastropediatrician, who assesses the patient's symptoms (PEESS score) and quality of life (PedsQL eosinophilic esophagitis module and PedsQL 4.0 Generic Core Scales).

If treatment needs to be introduced or changed, a digestive endoscopy with biopsies will be carried out at 3 months to determine whether the patient is in remission or not.

Interventions

  • Other Digestive endoscopy
    Digestive endoscopies are performed in the operative room under general anaesthetic 3 months after the introduction or change of treatment. Biopsies of the upper, middle and lower thirds of the esophagus will be taken and analyzed for pathology.

Primary outcome measures

  • Determine the rate of complete remission [Time frame: at 3 months, 6 months, 12 months, 18 months and 24 months from treatment initiation.]
Secondary outcome measures (2)
  • Description at inclusion of a cohort of pediatric patients with OE [Time frame: throught a 24 months follow-up]
  • evolution of quality of life [Time frame: at diagnosis, 3 months, 6 months, 12 months, 18 months and 24 months of treatment]

Eligibility criteria

Inclusion criteria

  • Diagnosis of OE according to the diagnostic criteria of the PNDS published in July 2022
  • Due to start treatment.
  • informed consent from one of the 2 parents or the representative of parental authority.
  • Membership of a social security scheme.

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

France · 1 center
  • Hôpitaux pédiatriques de Nice CHU Lenval — Nice

Identifiers

NCT: NCT06190080 · 23-HPNCL-05

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗